Skip to main content
Premium Trial:

Request an Annual Quote

BlueGnome to Market Rubicon Technology for IVF Studies

NEW YORK (GenomeWeb News) – BlueGnome will market Rubicon Genomics' technology along with its microarray-based aneuploidy chromosome screening and detection systems under a new non-exclusive agreement, Rubicon said today.

BlueGnome will market the PicoPlex technology to in vitro fertilization researchers under the name SurePlex DNA Amplification System. The PicoPlex technology can obtain "the same amount of genomic data from one cell as from 10,000," the company said, enabling researchers to produce five micrograms of amplified DNA in under three hours.

"We selected PicoPlex as the basis of SurePlex due to its rapid protocol, highly representative amplification and improved consistency over other amplification methods," Nick Haan, founder and CEO of BlueGnome, said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.